COVID-19

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

For December 2020, we have selected the following two papers: Zhang Q et al. ''COVID-19 case fatality and Parkinson’s disease'' and Bsteh G, et al. ''Multiple sclerosis and COVID-19: how many are at risk?''

COVID-19 around the World: Clinician interviews on experience and impact of the virus (New Zealand)

Headache medication and the COVID-19 pandemic by Headache Scientific Panel

COVID‐19 and Headache: A Primer for Trainees by Headache Scientific Panel

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia